# FDA Inspection 1265843 - Rigel Pharmaceuticals Inc - March 28, 2025

Source: https://www.keypedia.com/records/fda_inspections/rigel-pharmaceuticals-inc/c57bb907-aedf-4d06-8d8a-20b57fc033d1
Source feed: FDA_Inspections

> FDA Inspection 1265843 for Rigel Pharmaceuticals Inc on March 28, 2025. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1265843
- Company Name: Rigel Pharmaceuticals Inc
- Inspection Date: 2025-03-28
- Product Type: Human Drugs
- Office Name: San Francisco District Office

## Related Documents

- [FDA Inspection 1265843 - 2025-03-28](https://www.keypedia.com/records/fda_inspections/rigel-pharmaceuticals-inc/c0352afe-8df6-46b3-9b8a-9a2b3aee43f9)
- [FDA Inspection 1191864 - 2022-09-28](https://www.keypedia.com/records/fda_inspections/rigel-pharmaceuticals-inc/a860ea65-407d-4dd8-9751-d4f04d596ba9)
- [FDA Inspection 1028212 - 2017-08-23](https://www.keypedia.com/records/fda_inspections/rigel-pharmaceuticals-inc/a717e2f4-cf6f-4601-9df7-080bbd9b1a26)

Company: https://www.keypedia.com/companies/rigel-pharmaceuticals-inc/d9eb0a68-bb3f-4db0-86ac-6e28322ce2b6

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df